Rodman & Renshaw Begins Coverage on CAMP4 Therapeutics (NASDAQ:CAMP)

Research analysts at Rodman & Renshaw assumed coverage on shares of CAMP4 Therapeutics (NASDAQ:CAMP) in a research note issued on Tuesday, MarketBeat.com reports. The brokerage set a “buy” rating and a $7.00 price target on the Wireless communications provider’s stock. Rodman & Renshaw’s price target indicates a potential upside of 52.51% from the company’s current price.

A number of other research firms also recently commented on CAMP. Cantor Fitzgerald restated an “overweight” rating on shares of CAMP4 Therapeutics in a report on Friday, March 6th. Leerink Partners raised their price objective on CAMP4 Therapeutics from $8.00 to $9.00 and gave the stock an “outperform” rating in a report on Thursday, April 2nd. Finally, Weiss Ratings reiterated a “sell (e+)” rating on shares of CAMP4 Therapeutics in a report on Monday, December 29th. Five investment analysts have rated the stock with a Buy rating, one has given a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $8.60.

CAMP4 Therapeutics Price Performance

CAMP4 Therapeutics stock opened at $4.59 on Tuesday. The stock’s 50-day moving average is $4.61 and its 200-day moving average is $4.50. The company has a market cap of $238.31 million, a price-to-earnings ratio of -1.73 and a beta of 0.41. CAMP4 Therapeutics has a 12 month low of $1.30 and a 12 month high of $7.75.

CAMP4 Therapeutics (NASDAQ:CAMP) last released its quarterly earnings data on Thursday, March 5th. The Wireless communications provider reported ($0.87) EPS for the quarter, missing analysts’ consensus estimates of ($0.31) by ($0.56). The firm had revenue of $0.35 million during the quarter. CAMP4 Therapeutics had a negative return on equity of 162.49% and a negative net margin of 2,298.54%. Research analysts anticipate that CAMP4 Therapeutics will post -4.99 EPS for the current year.

Institutional Investors Weigh In On CAMP4 Therapeutics

Several hedge funds have recently modified their holdings of the stock. Janus Henderson Group PLC raised its holdings in shares of CAMP4 Therapeutics by 35.9% during the 4th quarter. Janus Henderson Group PLC now owns 6,307,636 shares of the Wireless communications provider’s stock valued at $38,807,000 after buying an additional 1,666,666 shares during the period. Vivo Capital LLC increased its holdings in CAMP4 Therapeutics by 8.3% during the 4th quarter. Vivo Capital LLC now owns 4,246,568 shares of the Wireless communications provider’s stock worth $26,031,000 after purchasing an additional 325,000 shares during the last quarter. Balyasny Asset Management L.P. purchased a new stake in CAMP4 Therapeutics during the 4th quarter worth approximately $14,938,000. Adage Capital Partners GP L.L.C. increased its holdings in CAMP4 Therapeutics by 11.3% during the 4th quarter. Adage Capital Partners GP L.L.C. now owns 2,181,679 shares of the Wireless communications provider’s stock worth $13,374,000 after purchasing an additional 220,895 shares during the last quarter. Finally, Geode Capital Management LLC increased its holdings in CAMP4 Therapeutics by 457.0% during the 4th quarter. Geode Capital Management LLC now owns 336,293 shares of the Wireless communications provider’s stock worth $2,063,000 after purchasing an additional 275,922 shares during the last quarter.

About CAMP4 Therapeutics

CalAmp Corp., a connected intelligence company, provides leverages a data-driven solutions ecosystem to people and organizations in the United States, Europe, the Middle East, Africa, Latin America, the Asia-Pacific, and internationally. The company operates in two segments, Software & Subscription Services and Telematics Products. It provides CalAmp Telematics Cloud platform, such as cloud-based application enablement and telematics service platforms that facilitate integration of its own applications, as well as those of third parties, through open application programming interfaces; and software as a service application, as well as provides tracking and monitoring services within fleet management, supply chain integrity, and international vehicle location.